intermittent fasting with tirzepatide At a glance factsheet: for the management of weight and diabetes ππ§πππ«π¦π’ππππ§π πππ¬ππ’π§π ππ¨ ππ«πππ ππ’ππππππ¬:
Description
Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies
%Daily Value
I get asked all the time: How did you decide to start a GLP-1
Find a qualified healthcare professional for guidance.
A subcutaneous injection (SQ or Sub-Q injection) is a shot administered just under the surface of the skin
